MO-0470 IMPT reduces esophageal and pulmonary toxicity compared to VMAT in stage II-IV NSCLC patients
- Hessels, A. (Speaker)
- R. Stoffers (Contributor)
- Niezink, A. (Contributor)
- Chouvalova, O. (Contributor)
- Ubbels, F. (Contributor)
- Annya Leest ,van der (Contributor)
- Woltman-van Iersel, M. (Contributor)
- Deseyne, P. (Contributor)
- Harriet J. Elzinga (Contributor)
- E. Haan-Stijntjes (Contributor)
- Korevaar, E. (Contributor)
- Pisciotta, P. (Contributor)
- Langendijk, J. A. (Contributor)
- Wijsman, R. (Contributor)
Activiteit: Academic presentation › Academic